Miriam Paramore is a seasoned executive with 30+ years of experience in healthcare and deep expertise in health information technology. As President of OptimizeRx, she is an officer of the company and is responsible for all day-to-day operations.
She is a Senior Advisor at NueCura, a Nashville-based healthcare angel investment company, as well as advisor to several venture and private equity firms. She is a member of Advisory Board of RxREVU, an early-stage prescription decision support company.
Previously, Paramore held executive roles in health IT companies including COO/CTO of digital health marketplace Lucro and EVP of retail pharmacy health IT vendor PDX. During her tenure as EVP of Strategy and Product at Emdeon, she reported to the CEO and helped lead the company to over $1.2 billion in revenues and largest health IT IPO in history.
Paramore is the architect of The U.S. Healthcare Efficiency Index™, the policy platform that resulted in the passage of the electronic healthcare payments provision of the Affordable Care Act. Since pioneering that work, the healthcare industry has experienced more than $1 billion in annual savings due to increased efficiencies in healthcare provider payment processing.
Paramore has held many Board positions including: CareSource, HIMSS, the Louisville Health Information Exchange, and the eHealth Committee for the Commonwealth of Kentucky. She is a member of the inaugural class of the Nashville Health Care Fellows Program and a member of Deloitte’s Life Sciences and Healthcare Women to Watch.
What is Miriam J. Paramore's net worth?
The estimated net worth of Miriam J. Paramore is at least $65,225.60 as of June 4th, 2021. Ms. Paramore owns 7,412 shares of OptimizeRx stock worth more than $65,226 as of April 26th. This net worth estimate does not reflect any other investments that Ms. Paramore may own. Learn More about Miriam J. Paramore's net worth.
How do I contact Miriam J. Paramore?
Has Miriam J. Paramore been buying or selling shares of OptimizeRx?
Miriam J. Paramore has not been actively trading shares of OptimizeRx in the last ninety days. Most recently, Miriam J. Paramore sold 3,558 shares of the business's stock in a transaction on Thursday, December 2nd. The shares were sold at an average price of $61.48, for a transaction totalling $218,745.84. Learn More on Miriam J. Paramore's trading history.
Who are OptimizeRx's active insiders?
Are insiders buying or selling shares of OptimizeRx?
During the last twelve months, insiders at the sold shares 1 times. They sold a total of 4,000 shares worth more than $60,760.00. The most recent insider tranaction occured on January, 9th when General Counsel Marion Odence-Ford sold 4,000 shares worth more than $60,760.00. Insiders at OptimizeRx own 4.4% of the company.
Learn More about insider trades at OptimizeRx. Information on this page was last updated on 1/9/2024.
